Flagship Biosciences, Inc. Asset Profile

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

Year established

2009

Location

Broomfield CO US

Primary Industry

Software

About

Established in 2009 and based in Colorado, US, Flagship Biosciences, Inc. operates as a biotechnology company that offers tissue analysis services. In October 2024, Astoriom, acquired Flagship Biosciences, Inc. from Ampersand Capital Partners, BroadOak Capital Partners, and Research Corporation Technologies. Financial terms of the transaction were not disclosed. Flagship Biosciences provides patented artificial intelligence image analysis technology-based biomarker and analytics services for its clients in the pharmaceutical and clinical diagnostic sectors. The company's suite of software and services offers precise cell measurements on a slide to identify biomarkers and spatial insights on cell samples for its customers, which aids them in accelerating their drug development process, helps with clinical diagnostics decision-making, and diagnostic services for high-tech patient care (TissueInsight®). The company’s full portfolio of services includes multiplex assays, IHC assays, IF assays and ISH assays, spatial multiplex services, molecular solutions, flow cytometry, and cytogenetics, immunoassays, bioinformatics solutions, biomarker discovery and development, integrated biorepository, data analysis, and reporting, consultation with scientific experts, and regulatory strategy and support services.

Current Investors

Ampersand Capital Partners, Research Corporation Technologies, BroadOak Capital Partners

Request a demo to show more

Primary Industry

Software

Sub Industries

Biopharmaceuticals, Pharmaceuticals, Medical Software

Website

www.flagshipbio.com

Verticals

Artificial Intelligence, HealthTech

Company Stage

Growth Stage/Expansion

Total Amount Raised

Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.